AGYS · Agilysys, Inc. · Stock research

Current Thesis

The proof print landed on 2026-07-27 and the tape took three weeks to price it. The 2026-08-14 close of $114.00 sits above the 2026-08-07 close of $108.58 that framed the prior note, RSI(14) has moved from 52.3 to 62.9, and that repricing happened while the market absorbed the largest insider block on file this year: CEO Ramesh Srinivasan sold 197,410 shares for $21,285,243 between 2026-08-05 and 2026-08-07 at prices of $106.60 to $109.63 (Form 4s). Needham raised its target a second time on 2026-08-10, to $135 from the $130 set on 2026-07-28. The narrative leg on offer is the back half of a legacy-POS-licence-to-PMS-subscription re-rate whose fundamentals are now filed rather than forecast — Q1 FY2027 revenue $87.7M (+14.3% YoY), recurring at 65.9% of total, FY2027 guidance lifted to $368–373M with subscription growth to "at least 32%". What it lacks is a dated gate: nothing scheduled resolves anything before the Q2 print in roughly ten weeks, and the name has already run 69.3% in three months.

Bullish and bearish views on Agilysys, Inc.

The model's bull view on Agilysys, Inc. (AGYS), in brief: Guidance moved up one quarter into the year. The bear view: Q1 subscription growth was 26.1%; the full-year guide is at least 32%. Both cases follow in full.

Bull Case

• Guidance moved up one quarter into the year. FY2027 revenue range raised to $368–373M from $365–370M and full-year subscription growth to "at least 32%" from "at least 30%" (2026-07-27 release).
• The mix crossed the line the story is priced on. Q1 FY2027 recurring revenue a record $57.7M, 65.9% of total net revenue, versus $48.6M and 63.4% a year earlier; PMS-and-related-module subscription revenue +39.7% YoY, and PMS subscription revenue exceeded POS subscription revenue for the first time (2026-07-27 earnings call).
• The beat carried margin with it. Adjusted diluted EPS $0.49 against $0.40 consensus; gross margin 63.5% vs 61.7%; adjusted EBITDA $18.3M at a 20.8% margin; GAAP net income $9.0M (2026-07-27).
• Sell-side numbers are still moving up. Needham to $135 on 2026-08-10, a second raise within fourteen days, after Needham $130 and Piper Sandler Overweight $120 on 2026-07-28. public.com's aggregation of nine analysts in mid-August showed a median $125 target, a $120–$152 range and no Hold or Sell ratings.
• The supply was met. Roughly $21.3M of CEO stock cleared between 2026-08-05 and 2026-08-07 against 28,205,788 shares outstanding, and the 2026-08-14 close of $114.00 is above every price in that sale.
• The rollout is self-funded. Cash and equivalents $123.7M and free cash flow $7.3M in Q1 FY2027 (2026-07-27).

Bear Case

• Q1 subscription growth was 26.1%; the full-year guide is at least 32%. MEASURED: 26.1% in Q1 FY2027 against +30.2% for FY2026 as a whole ($137.1M subscription, reported 2026-05-18). INFERRED: the guide requires acceleration across the three remaining quarters, so the quarter already banked runs below the rate the year needs.

• The lumpy lines are unchanged. Product revenue $10.3M and professional services $19.6M in Q1 FY2027 — the one-time and timing-sensitive components behind the 2026-01-21 session, when revenue printed $69.6M against $73.1M expected alongside a guidance cut and shares fell roughly 25% intraday.
• Nothing dated resolves before late October. The 2026-09-02 annual meeting is procedural. Between it and the Q2 FY2027 print (~2026-10-26 est.) there is no scheduled disclosure to convert momentum into new information.
• The re-rate is a recovery, not a discovery. Price remains 19.2% below the $141.12 52-week high despite three consecutive record revenue quarters since the January 2026 de-rate.
• A fresh buyer's arithmetic is worse than in June. RSI(14) 62.9 on 2026-08-14 after a 69.3% three-month return, with the ~$92 June shelf that framed the July advance far below.

Setup & Price Structure

The narrative is maturing. Dating it — the binary resolved on 2026-07-27 with a beat and a raise; targets were lifted 2026-07-28 and again 2026-08-10; coverage is nine analysts with zero Hold or Sell ratings; price is printing higher closes but has not reclaimed the $141.12 high set before January 2026. Incremental attention is not arriving from new participants; the same small sell-side group is marking models up. Working narrative, moderating flow.

Structure as of the 2026-08-14 close of $114.00:

• $106.60–$109.63 is now a documented supply shelf. It contains the 2026-07-10 pre-print close of $108.98, the 2026-08-07 close of $108.58, and every fill in the CEO's three-day sale. Trading above it is the observable that the distribution was absorbed.
• Below that, the ~$92 June area is the higher-low from which the July advance started; ~$98 marks the rising 20-EMA that guided that advance.
• Above, there is no twelve-month resistance until the $120 Piper Sandler target zone, then the $135 Needham target; $141.12 is the structural ceiling of the pre-January regime.
• RSI(14) 62.9 on 2026-08-14, up from 52.3 a week earlier — elevated, short of the >70 zone.

Crowding and positioning observables, stated as observables: 197,410 insider shares sold into the post-print level across three sessions; 28,205,788 shares outstanding, so single-holder decisions carry weight; nine covering analysts, no Hold or Sell; the 2026-08-14 close below both the $125 aggregated median and the $135 high-side named target; no earnings date inside 30 days; a 69.3% three-month return with price still 19.2% under the 52-week high.

Catalyst Calendar (next 30 days)

• 2026-09-02 — 2026 Annual Meeting of Stockholders, 5:00pm ET, virtual at meetnow.global/AGYS2026, per DEF 14A filed 2026-07-16. Director elections, auditor ratification, say-on-pay. The only thesis-relevant content would be management commentary on FY2027 subscription cadence; absent that, the date passes without resolving anything.
• ~2026-10-26 (est.) — Q2 FY2027 results, quarter ending 2026-09-30. Outside the window, and the first date that tests the "at least 32%" subscription guide against the 26.1% Q1 rate.

Elapsed catalysts

• Rolling from 2026-08-16 — further Form 4 / Form 144 filings on EDGAR. The 2026-08-05/06/07 Form 4s document completed CEO sales; whether additional notices follow distinguishes a one-off liquidation from a program. (passed 10d ago)

What Would Change Our Mind

The structure that defines the current read is the $106.60–$109.63 shelf: pre-print and post-print closes plus the entire CEO sale cleared inside it, and price holding above makes the absorption claim checkable rather than rhetorical. Losing it puts the August advance back inside distribution. Gradeable version: a daily close below $105 breaks the shelf; a weekly close below $98 fails the July advance and the rising 20-EMA that guided it, returning the name to the ~$92–$109 range it occupied through the spring.

On fundamentals, subscription growth is the datapoint that flips the frame. Q2 FY2027 (~2026-10-26) printing subscription growth at or below the 26.1% recorded in Q1, or FY2027 language reverting to "at least 30%", would show the acceleration the guide requires is not arriving. A revenue print below consensus with product revenue under $10.3M alongside unchanged or lowered guidance repeats the 2026-01-21 mechanism directly.

On the calendar, if 2026-09-02 passes with only procedural business — the ordinary outcome for an annual meeting — the name carries no scheduled information for roughly eight weeks and has to hold on price action alone. A drift back under the shelf during that stretch, with sell-side targets static, is what a maturing label turning saturated looks like in this name.

Correlation Notes

• Small/mid-cap vertical SaaS beta. AGYS moves with the hospitality-software complex (Toast, PAR Technology, Lightspeed) and the broader software index; a group de-rate can compress the multiple with no change in bookings. Observable: AGYS making lower highs on sessions where results are in line and peers sell off.
• Hospitality capex. Revenue depends on hotel, casino and resort property-technology budgets. Observable: property-level capex or technology-spend guidance from large operators (Marriott, Hilton, MGM, Caesars) at their Q3 2026 reports, and any Agilysys commentary on elongated sales cycles.
• The Marriott PMS rollout signed in December 2022 is multi-year and back-end loaded, and management has warned against expecting an even quarterly cadence — so a single quarter's deal count is a weak read on the underlying rollout pace.
• Float mechanics. With 28,205,788 shares outstanding (Form 144, August 2026), index rebalances and single-holder liquidations move price more than a headline market cap implies; the 2026-08-05/07 CEO sale is the live example of that mechanism working through the tape.